Oxidative stress and inflammation caused by reactive oxygen species (ROS) imbalance are the origins for inducing various chronic diseases in multiple organs. The core mechanism of botanical new drug BEL-X is to inhibit ROS production resulting in reduction of the oxidative stress and the inflammation to maintain oxidative stress balance in the cells. The current selected indications of botanical BEL-X include viral infected chronic diseases, liver diseases, cancers, sarcopenia, and aging related chronic diseases.
Innovation
• Innovative technologies patent layout
• Novel mechanism of action
• Single/combination therapies for multiple diseases Refinement
• Botanical new drug development platform
• Quality control in drug manufacturing (PIC/S-cGMP)
• DNA authentication and quality control of raw material (GACP plantation) Inheritance
• Long history of human use experience
• Single medicinal plant with well-known therapeutic effects
• Less side effects and low toxicity
Copyright (c) 2020 BELX Bio-Pharmaceutical (Taiwan) Corporation. All rights reserved